WHO Drug Dictionary, IDMP & Product Identification · Section 16.1
~5 min read · The Drug Safety Coach — Global PV Career Course
This module's video isn't published yet
Visit the channel →Key points
Full text
Module 4 built MedDRA coding in real depth — the discipline of correctly identifying and coding the event side of every case: what happened to the patient. This module covers the equally consequential but far less commonly taught counterpart: how the drug itself, the product side of every case, gets identified in the first place. It’s a genuine, standard, currently-taught specialty within pharmacovigilance — EMA runs dedicated XEVMPD training, WHO-UMC provides IDMP training and tooling, and DIA runs regular webinars specifically on this subject — not a niche technicality invented for this course.
The problem this module solves is structurally identical to the problem Module 4 solved for events, just applied to products instead: without a standardised way to identify a medicinal product, the same actual medicine can be recorded completely differently across different databases, different countries, and different companies. A brand name in one market, a different brand name in another, a generic name somewhere else, a specific strength-and-formulation combination recorded as free text in a fourth place — all referring to the exact same product, but with nothing structurally linking those records together.
The consequence of that fragmentation is precisely the same consequence Module 4 warned about for inconsistent event coding: cases that should be analysed as a group — because they involve the same actual product — end up scattered across records a disproportionality analysis or a signal detection system simply can’t recognise as related. A genuine safety signal affecting a specific product can hide in plain sight, split across multiple differently-recorded identities of the exact same medicine, invisible to exactly the kind of aggregate analysis Module 7 built in depth.
This module works through that problem in the order it actually gets solved: the WHO Drug Dictionary as the traditional, long-standing approach to standardising drug names globally, the five ISO IDMP standards as the newer, more structurally rigorous international framework superseding it, the EU’s specific XEVMPD and SPOR infrastructure implementing IDMP in practice, and finally, concretely, how product identification quality feeds directly into the signal detection accuracy this course has built since Module 7.
Important
A drug can be recorded as a specific brand name in one country, a different brand name in another, a generic name in a third, and a molecule-plus-strength combination in a fourth — all referring to the exact same medicinal product. Without a standardised identification system linking all of those records together, a genuine safety signal affecting that product can be invisibly scattered across records that never get analysed as a group.
Quick check
Test yourself before moving on — no pressure, just click an answer.
1. What is the structural problem this module addresses, and how does it parallel Module 4’s MedDRA coding content?